Solabegron (BioDeep_00000837785)
代谢物信息卡片
化学式: C23H23ClN2O3 (410.1397118)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)NCCNCC(C3=CC(=CC=C3)Cl)O
InChI: InChI=1S/C23H23ClN2O3/c24-20-8-2-6-18(13-20)22(27)15-25-10-11-26-21-9-3-5-17(14-21)16-4-1-7-19(12-16)23(28)29/h1-9,12-14,22,25-27H,10-11,15H2,(H,28,29)/t22-/m0/s1
描述信息
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
Solabegron (GW 427353) is a selective β3-adrenergic receptor agonist, stimulating cAMP accumulation in Chinese hamster ovary cells expressing the human β3-AR, with an EC50 value of 22 nM[1]. Solabegron (GW 427353) is being developed for the treatment of overactive bladder and irritable bowel syndrome[1].
同义名列表
2 个代谢物同义名
数据库引用编号
7 个数据库交叉引用编号
- ChEBI: CHEBI:141346
- KEGGdrug: D93408
- PubChem: 9887812
- DrugBank: DB06190
- ChEMBL: CHEMBL208427
- CAS: 252920-94-8
- medchemexpress: HY-19436
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Shakti Sahi, Parul Tewatia, Balwant K Malik. Modeling and simulation studies of human β3 adrenergic receptor and its interactions with agonists.
Current computer-aided drug design.
2012 Dec; 8(4):283-95. doi:
10.2174/157340912803519633. [PMID: 22242799] - Eliot H Ohlstein, Alexander von Keitz, Martin C Michel. A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder.
European urology.
2012 Nov; 62(5):834-40. doi:
10.1016/j.eururo.2012.05.053. [PMID: 22695239] - April B M Grudell, Michael Camilleri, Kim L Jensen, Amy E Foxx-Orenstein, Duane D Burton, Michael D Ryks, Kari L Baxter, Donna S Cox, George E Dukes, Dennis L Kelleher, Alan R Zinsmeister. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.
American journal of physiology. Gastrointestinal and liver physiology.
2008 May; 294(5):G1114-9. doi:
10.1152/ajpgi.00051.2008. [PMID: 18372395] - Masashi Imanishi, Yasuyo Tomishima, Shinji Itou, Hitoshi Hamashima, Yutaka Nakajima, Kenichi Washizuka, Minoru Sakurai, Shigeo Matsui, Emiko Imamura, Koji Ueshima, Takao Yamamoto, Nobuhiro Yamamoto, Hirofumi Ishikawa, Keiko Nakano, Naoko Unami, Kaori Hamada, Yasuhiro Matsumura, Fujiko Takamura, Kouji Hattori. Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
Journal of medicinal chemistry.
2008 Mar; 51(6):1925-44. doi:
10.1021/jm701324c. [PMID: 18307290]